Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPsychotropic Medication During Pregnancy
U.S. Pharmacist, 09/22/09
Baylor SD et al. – Depression, mood disorders, and other psychiatric disorders are prevalent, with the highest incidence occurring at the onset of the childbearing years in women. It is important to weigh the risks and benefits of all treatment options during pregnancy. Untreated depression, psychosis, and mood disorders can have ill effects on both the patient and the infant; however, pharmacotherapy also may cause negative outcomes for the baby. Because of this, it is important for the patient taking psychotropics to have a thorough discussion with her HCP about whether to continue or discontinue pharmacotherapy during pregnancy.
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09
Statin use and neurologic morbidity after coronary artery bypass grafting. A cohort study
Neurology, 11/16/09
Sponsor
Article Search
Sponsor